Loading clinical trials...
Loading clinical trials...
The purpose of this study is to measure blood levels of TXA in children having cardiac surgery which requires cardiopulmonary bypass. TXA is used to reduce bleeding during surgery. This study will help determine if the current dosing of TXA results in therapeutic blood levels.
Age
0 - 21 years
Sex
ALL
Healthy Volunteers
Yes
Children's Hospital Boston
Boston, Massachusetts, United States
Start Date
January 1, 2010
Primary Completion Date
November 1, 2014
Completion Date
December 1, 2014
Last Updated
July 30, 2015
55
ACTUAL participants
Lead Sponsor
Boston Children's Hospital
NCT05647213
NCT07042334
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions